(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MIRA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MIRA

ST13

US500000079288636

Classe

1, 5, 9, 10

Pedido

79288636

Registro

6436346

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

03/08/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10

Data de depósito

20/05/2020

Data de registro

03/08/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

03/08/2021

Última transação

03/08/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

DE

Examinador

NADELMAN, ANDREA KOYNER

Unidade examinadora

M10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Spindiag GmbH

Representantes

Ursula B. Day Law Firm of Ursula B. Day

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical products for diagnostic uselaboratory chemicals in the nature of nucleic acid amplification reagents used for the detection of nucleic acids of pathogens for in vitro diagnostic use for scientific purposeschemical preparations for scientific diagnostic purposes; chemical reagents for chemical analyses for non­ medical purposes; chemical reagents for use in diagnostic testsother than for medical or veterinary use; chemical reagents for use in analytical testsother than for medical or veterinary use; chemical reagents for laboratory useother than for medical or veterinary use; nucleic acid for use in nucleic acid amplification processes other than for medical or veterinary use; chemicals for use in performing nucleic acid polymerase chain reactions for scientific purposesother than for medical or veterinary use; chemical reagentsother than for medical or veterinary purposes; diagnostic reagents for scientific or research use; nucleic acid amplification reagents other than for medical or veterinary use

Classe 5

Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; reagents for medical use; chemical preparations for testing blood for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical purposes for detecting the presence of pathogenic bacteriavirusesfungi and parasites; diagnostic preparations and materialsdiagnostic preparations for veterinary purposes and diagnostic preparations for medical purposes; clinical diagnostic reagents for medical purposes

Classe 9

Computer hardware and recorded and downloadable software for diagnostic purposesfor operating and configuring processing apparatus for diagnostic tests and displaying apparatus for diagnostic results in relation to infectious diseases; mobile apps for diagnostic purposesdownloadable mobile applications for use in data management of diagnostic results and in management of diagnostic apparatus in relation to infectious diseases; laboratory apparatus and instruments for diagnostic purposesdiagnostic apparatus for the detection of pathogens for laboratory use; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; all the aforementioned goods in relation to diagnostic purposes for infectious diseasesnone used in relation to immunochemical testing but including immunoassay technologies

Classe 10

Apparatusinstruments and equipment for diagnostic purposesdiagnostic apparatus for the detection of pathogenic bacteriavirusesfungi and parasites for medical purposes; automatic analyzers for medical diagnosisnucleic acid amplification and detection apparatus; analyzers for bacterial identification for medical purposes; apparatus for analyzing bacteria in biological samples for medical use; automated analyzers for body fluids for medical use in the nature of medical diagnostic instruments for the analysis of body fluids; automated analyzers for foreign matter contained in body fluidspathogenic bacteriavirusesfungi and parasites contained in body fluids for medical use in the nature of medical diagnostic instruments for the analysis of foreign matter contained in body fluidsof pathogenic bacteriavirusesfungi and parasites contained in body fluids; electronic analyzers for medical purposesapparatus for nucleic acid amplification and detection for medical diagnostics; photometric and fluorescence-based analyzers of nucleic acid amplification reactions for medical use; physical analyzers of pathogenic bacteriavirusesfungi and parasites for medical use; genetic testing apparatus for medical purposes in the nature of apparatus for nucleic acid testing for medical purposes; blood testing apparatus; apparatus for blood analysis for medical use; automatic analyzers in the nature of nucleic acid analyzers for medical diagnostic uses; diagnostic apparatus for medical purposesfor testing for pathogenic bacteriavirusesfungi and parasites as well as their resistances; analyzers for medical usemedical instruments for analyzing and identifying pathogenic bacteriavirusesfungi and parasites; diagnostic test kits comprised of enzymesoligonucleotides and further nucleic acid amplification and detection reagents for detecting the existence of multi-resistant germs in human body fluids and of blood disorders; all the aforementioned goods in relation to diagnostic purposes for infectious diseases and not including brushes related goods nor used in relation to immunochemical testing but including immunoassay technologies

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/08/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

21/03/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

29/01/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/01/2022

FIMP

FINAL DISPOSITION PROCESSED

06/01/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/11/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2021

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

30/06/2021

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

19/05/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/04/2021

PUBO

PUBLISHED FOR OPPOSITION

20/04/2021

GPNX

NOTIFICATION PROCESSED BY IB

18/04/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

31/03/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

31/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

31/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

17/03/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

17/03/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

17/03/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

17/03/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

17/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/02/2021

ATRV

ATTORNEY REVIEW COMPLETED

03/02/2021

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

03/02/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

03/01/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/10/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/10/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/10/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/10/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/10/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/10/2020

RFNT

REFUSAL PROCESSED BY IB

27/09/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/09/2020

RFRR

REFUSAL PROCESSED BY MPU

21/08/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

16/07/2020

CNRT

NON-FINAL ACTION WRITTEN

15/07/2020

MAFR

APPLICATION FILING RECEIPT MAILED

14/07/2020

DOCK

ASSIGNED TO EXAMINER

13/07/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/07/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/07/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MIRA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.